查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954693

败血症诊断市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2026-2034年）

Sepsis Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 185 Pages | 商品交期: 请询问到货日

价格

败血症诊断市场成长驱动因素

2025年全球脓毒症诊断市场规模为 10.0395亿美元，预计将从2026年的10.9922亿美元成长至2034年的23.9934亿美元，预测期内（2026-2034年）年复合成长率（CAGR）为 10%。北美地区在2025年占据市场主导地位，市场占有率达 51.50%。这主要受疾病高发病率、有利的偿付政策以及先进诊断技术的快速普及所驱动。

败血症是一种危及生命的疾病，由人体对感染的过度反应引起，可导致组织损伤、器官衰竭甚至死亡。虽然细菌感染是最常见的原因，但病毒和真菌感染也可能导致败血症。此疾病分为三个阶段：败血症、重症败血症和败血性休克。根据世界卫生组织（WHO）统计，2017年全球约有 4,900万人感染败血症，1,100万人死亡，凸显了早期准确诊断的紧迫性。

市场动态

全球脓毒症发生率的上升是市场成长的主要驱动因素。光是在美国，每年就有约 170万成年人罹患败血症，约 35万人在住院或安宁疗护期间死亡。住院率上升和医疗相关感染（HAI）的增加进一步推动了对可靠诊断解决方案的需求。

优惠的偿付政策，尤其是在已开发国家，为住院和诊断程序提供了支持。此外，全球脓毒症联盟和世界卫生组织等国际组织扩大了宣传活动，有助于早期发现和推广标准化治疗方案。

2020年，由于感染患者中脓毒症发生率的增加，COVID-19 疫情对市场产生了轻微的正面影响。到2021年，患者就诊量和公司收入已恢復到疫情前水准，支撑了整个预测期内的稳定成长。

主要市场趋势

败血症诊断市场的一个显着趋势是快速诊断和即时检测（POC）技术的日益普及。与传统方法相比，这些解决方案能够提供更快、更准确的结果，实现及时的临床干预。快速检测减少了对大型实验室基础设施和熟练人员的依赖，缓解了许多医疗系统面临的劳动力短缺问题。

2023年11月，Inflammatix完成了其TriVerity急性感染和脓毒症检测系统的技术开发，获得了美国FDA的突破性医疗器械认定，并加速了其商业化进程。此类技术进步显着提高了诊断的速度和效率。

成长因素

全球脓毒症病例的快速成长持续推动着对有效诊断解决方案的需求。住院患者尤其脆弱，研究表明，约三分之一的医院死亡病例与败血症有关。医疗系统日益沉重的负担进一步加剧了对早期检测技术的需求。

新兴市场意识的提高也促进了市场扩张。各国政府和非政府组织正努力推广筛检计画、教育和败血症应对方案，以降低死亡率。诸如全球孕产妇败血症研究与运动（GLOSS）等倡议促进全球对败血症的认识不断提高，并推广诊断方法。

抑制因子

儘管成长前景广阔，但高昂的诊断成本是推广应用的一大障碍。败血症的诊断通常需要进行多项检测，增加了总成本。例如，英国每年与败血症相关的直接和间接成本估计为 92.4亿美元。在新兴市场，单一检测的费用可能成为患者的经济负担，并限制他们获得及时诊断的机会。

此外，缺乏单一的确诊检测方法以及对复杂临床评估的依赖也带来了营运方面的挑战。

市场区隔分析

依产品类型

试剂和耗材细分市场占据主导地位，在2026年的市场占有率达到 77.22%，这主要得益于医院和实验室的持续需求。由于技术进步和新产品的推出，仪器领域预计将保持稳定成长。

依技术划分

由于血液培养的广泛应用和成本效益，微生物学领域在2026年占据了58.85%的市场占有率。免疫分析占据了第二大占有率，但分子诊断因其高灵敏度和快速出结果而备受关注。

依方法划分

由于其高特异性和快速病原体检测能力，预计自动化检测在2026年将占据93.26%的主导市场占有率。传统方法由于价格实惠，在低收入地区仍然很重要。

依侦测类型划分

由于住院率和重症监护室（ICU）入院率高，实验室检测占据主导地位。然而，由于其成本效益高且能快速提供结果，即时检测预计将呈现最高的成长率。

依病原体分类

细菌感染仍然是败血症的主要原因，因此细菌感染占据最大市场占有率。真菌诊断是第二大细分市场。

依最终使用者分类

医院和诊所占据市场主导地位。这主要是由于加护病房（ICU）收治人数众多以及院内诊断需求量大。

区域洞察

到2025年，北美将继续引领市场，市场规模将达到 5.171亿美元。强大的医疗保健基础设施、技术创新和政府支持推动该地区的成长。

欧洲将占据第二大市场，这得益于监管审批和熟练的专业人员。由于公众意识的提高、临床指南的更新（例如日本的J-SSCG2021）以及医疗基础设施的不断完善，亚太地区预计将迎来显着成长。

主要行业参与者

主要参与者包括 bioMerieux SA、Danaher、Thermo Fisher Scientific Inc.、BD、Abbott、Siemens Healthcare GmbH、T2 Biosystems、Luminex Corporation（DiaSorin S.p.A.）和 Bruker。策略联盟、监管审批和产品上市增强它们的竞争地位。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要发现

  • 主要地区脓毒症发生率（2025年）
  • 新产品上市
  • 主要产业发展动态（併购、合作等）
  • 败血症诊断技术进步
  • 主要地区的监管和偿付情况
  • 新冠疫情的影响败血症诊断市场

第5章 全球败血症诊断市场分析、洞察与预测（2021-2034）

  • 依产品类型划分的市场分析、洞察与预测
    • 设备
    • 试剂和耗材
  • 依技术划分的市场分析、洞察与预测
    • 微生物学
    • 分子诊断
    • 免疫分析
    • 其他
  • 依方法划分的市场分析、洞察与预测
    • 传统方法
    • 自动化方法
  • 依检测类型划分的市场分析、洞察与预测
    • 实验室检测
    • 即时检测
  • 依病原体划分的市场分析、洞察与预测
    • 细菌
    • 真菌
    • 其他病原体
  • 依最终用户划分的市场分析、洞察与预测
    • 医院和诊所
    • 诊断中心
    • 其他
  • 依地区划分的市场分析、洞察与预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 世界其他地区

第6章 北美败血症诊断市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲败血症诊断市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第8章 亚太地区败血症诊断市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 其他亚太地区

第9章 全球其他地区败血症诊断市场分析、洞察与预测（2021-2034）

第10章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • T2 Biosystems, Inc.
    • Danaher
    • Abbott
    • bioMerieux SA
    • Thermo Fisher Scientific Inc.
    • Luminex Corporation（DiaSorin S.p.A.）
    • BD（Becton, Dickinson, and Company）
    • Bruker
    • Siemens Healthcare GmbH
Product Code: FBI107417

Growth Factors of sepsis diagnostics Market

The global sepsis diagnostics market size was valued at USD 1,003.95 million in 2025 and is projected to grow from USD 1,099.22 million in 2026 to USD 2,399.34 million by 2034, exhibiting a CAGR of 10.20% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for a 51.50% share, driven by high disease incidence, favorable reimbursement policies, and rapid adoption of advanced diagnostic technologies.

Sepsis is a life-threatening condition caused by the body's extreme response to infection, leading to tissue damage, organ failure, and potentially death. Bacterial infections are the most common cause, though viral and fungal infections can also trigger the condition. The three stages include sepsis, severe sepsis, and septic shock. According to the World Health Organization (WHO), approximately 49 million people were affected globally in 2017, resulting in 11 million deaths, highlighting the urgent need for early and accurate diagnostics.

Market Dynamics

The rising global incidence of sepsis is a major factor driving market growth. In the U.S. alone, around 1.7 million adults develop sepsis annually, with nearly 350,000 deaths occurring during hospitalization or hospice care. Increased hospitalization rates and healthcare-associated infections (HAIs) further elevate demand for reliable diagnostic solutions.

Favorable reimbursement policies, especially in developed countries, support hospital admissions and diagnostic procedures. Additionally, growing awareness initiatives by global organizations such as the Global Sepsis Alliance and WHO are promoting early detection and standardized treatment protocols.

The COVID-19 pandemic had a slightly positive impact on the market in 2020 due to increased sepsis incidence among infected patients. By 2021, patient visits and company revenues returned to pre-pandemic levels, supporting stable growth through the forecast period.

Key Market Trends

A prominent trend in the sepsis diagnostics market is the increasing adoption of rapid diagnostic and point-of-care (POC) technologies. These solutions provide faster and more accurate results compared to conventional methods, enabling timely clinical intervention. Rapid tests reduce dependency on extensive laboratory infrastructure and skilled personnel, addressing workforce shortages in many healthcare systems.

In November 2023, Inflammatix completed technical development of its TriVerity Acute Infection and Sepsis Test System and received U.S. FDA Breakthrough Device Designation, accelerating commercialization efforts. Such technological advancements are significantly enhancing diagnostic speed and efficiency.

Growth Drivers

The exponential rise in global sepsis cases continues to fuel demand for effective diagnostic solutions. Hospitalized patients are particularly vulnerable, with studies indicating that nearly one in three hospital deaths involves sepsis. The increasing burden on healthcare systems strengthens the need for early detection technologies.

Growing awareness in emerging markets further contributes to market expansion. Government and non-government initiatives are promoting screening programs, education, and implementation of sepsis bundles to reduce mortality. Campaigns such as the Global Maternal Sepsis Study and Campaign (GLOSS) are improving awareness and encouraging diagnostic adoption globally.

Restraining Factors

Despite strong growth prospects, high diagnostic costs limit broader adoption. Sepsis diagnosis typically requires multiple tests, increasing overall expenses. For example, annual direct and indirect costs related to sepsis in the U.K. are estimated at USD 9.24 billion. In emerging countries, individual test costs can create financial burdens for patients, restricting access to timely diagnosis.

Additionally, the absence of a single definitive diagnostic test and reliance on combined clinical assessments pose operational challenges.

Market Segmentation Analysis

By Product Type

The reagents & consumables segment dominated with a 77.22% market share in 2026, driven by recurring demand across hospitals and laboratories. The instruments segment is projected to grow steadily due to technological advancements and new product launches.

By Technology

The microbiology segment accounted for 58.85% of the market share in 2026, owing to widespread use of blood cultures and cost-effectiveness. Immunoassays represent the second-largest segment, while molecular diagnostics are gaining traction due to higher sensitivity and faster results.

By Method

The automated segment held a dominant 93.26% share in 2026, attributed to high specificity and rapid pathogen detection capabilities. Conventional methods maintain relevance in low-income settings due to affordability.

By Test Type

Laboratory tests dominate due to high hospitalization rates and ICU admissions. However, point-of-care tests are expected to witness the highest growth rate due to their cost-effectiveness and rapid results.

By Pathogen

The bacterial segment holds the largest share, as bacterial infections remain the leading cause of sepsis. Fungal diagnostics represent the second-largest segment.

By End User

Hospitals & clinics dominate the market, given the high volume of ICU admissions and in-hospital diagnostics.

Regional Insights

In 2025, North America generated USD 517.1 million, maintaining market leadership. Strong healthcare infrastructure, technological innovation, and government support drive regional growth.

Europe ranks as the second-largest market, supported by regulatory approvals and skilled professionals. Asia Pacific is projected to experience significant growth due to rising awareness, updated clinical guidelines (such as Japan's J-SSCG 2021), and expanding healthcare infrastructure.

Key Industry Players

Leading companies include bioMerieux SA, Danaher, Thermo Fisher Scientific Inc., BD, Abbott, Siemens Healthcare GmbH, T2 Biosystems, Luminex Corporation (DiaSorin S.p.A.), and Bruker. Strategic partnerships, regulatory approvals, and product launches are strengthening competitive positioning.

Conclusion

The global sepsis diagnostics market is poised for strong expansion, growing from USD 1,003.95 million in 2025 to USD 2,399.34 million by 2034, at a CAGR of 10.20%. Increasing disease prevalence, rapid adoption of automated and point-of-care diagnostics, and strong awareness initiatives are driving growth. Although high diagnostic costs pose challenges, technological advancements and global healthcare improvements are expected to sustain long-term market expansion across key regions.

Segmentation By Product Type

  • Instruments
  • Reagents & Consumables

By Technology

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Others

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial
  • Fungal
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

By Region

  • North America (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country)
    • U.S. (By Product Type)
    • Canada (By Product Type)
  • Europe (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country/Sub-Region)
    • Germany (By Product Type)
    • U.K. (By Product Type)
    • France (By Product Type)
    • Italy (By Product Type)
    • Spain (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country/Sub-Region)
    • China (By Product Type)
    • India (By Product Type)
    • Japan (By Product Type)
    • Australia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Rest of the World (By Product Type, Technology, Method, Test Type, Pathogen, and End User)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Sepsis Incidence, By Key Regions, 2025
  • 4.2. New Product Launches
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Technological Advancements in Sepsis Diagnostics
  • 4.5. Regulatory & Reimbursement Scenario, Key Regions
  • 4.6. Impact of COVID-19 Pandemic on Sepsis Diagnostics Market

5. Global Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Consumables
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Microbiology
    • 5.2.2. Molecular Diagnostics
    • 5.2.3. Immunoassays
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Method
    • 5.3.1. Conventional
    • 5.3.2. Automated
  • 5.4. Market Analysis, Insights and Forecast - By Test Type
    • 5.4.1. Laboratory Tests
    • 5.4.2. Point-of-Care Tests
  • 5.5. Market Analysis, Insights and Forecast - By Pathogen
    • 5.5.1. Bacterial
    • 5.5.2. Fungal
    • 5.5.3. Other Pathogens
  • 5.6. Market Analysis, Insights and Forecast - By End User
    • 5.6.1. Hospitals & Clinics
    • 5.6.2. Diagnostic Centres
    • 5.6.3. Others
  • 5.7. Market Analysis, Insights and Forecast - By Region
    • 5.7.1. North America
    • 5.7.2. Europe
    • 5.7.3. Asia Pacific
    • 5.7.4. Rest of the World

6. North America Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Consumables
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Microbiology
    • 6.2.2. Molecular Diagnostics
    • 6.2.3. Immunoassays
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Method
    • 6.3.1. Conventional
    • 6.3.2. Automated
  • 6.4. Market Analysis, Insights and Forecast - By Test Type
    • 6.4.1. Laboratory Tests
    • 6.4.2. Point-of-Care Tests
  • 6.5. Market Analysis, Insights and Forecast - By Pathogen
    • 6.5.1. Bacterial
    • 6.5.2. Fungal
    • 6.5.3. Other Pathogens
  • 6.6. Market Analysis, Insights and Forecast - By End User
    • 6.6.1. Hospitals & Clinics
    • 6.6.2. Diagnostic Centres
    • 6.6.3. Others
  • 6.7. Market Analysis, Insights and Forecast - By Country
    • 6.7.1. U.S.
      • 6.7.1.1. By Product Type
    • 6.7.2. Canada
      • 6.7.2.1. By Product Type

7. Europe Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Consumables
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Microbiology
    • 7.2.2. Molecular Diagnostics
    • 7.2.3. Immunoassays
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Method
    • 7.3.1. Conventional
    • 7.3.2. Automated
  • 7.4. Market Analysis, Insights and Forecast - By Test Type
    • 7.4.1. Laboratory Tests
    • 7.4.2. Point-of-Care Tests
  • 7.5. Market Analysis, Insights and Forecast - By Pathogen
    • 7.5.1. Bacterial
    • 7.5.2. Fungal
    • 7.5.3. Other Pathogens
  • 7.6. Market Analysis, Insights and Forecast - By End User
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostic Centres
    • 7.6.3. Others
  • 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.7.1. Germany
      • 7.7.1.1. By Product Type
    • 7.7.2. U.K.
      • 7.7.2.1. By Product Type
    • 7.7.3. France
      • 7.7.3.1. By Product Type
    • 7.7.4. Spain
      • 7.7.4.1. By Product Type
    • 7.7.5. Italy
      • 7.7.5.1. By Product Type
    • 7.7.6. Rest of Europe
      • 7.7.6.1. By Product Type

8. Asia Pacific Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Consumables
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Microbiology
    • 8.2.2. Molecular Diagnostics
    • 8.2.3. Immunoassays
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Method
    • 8.3.1. Conventional
    • 8.3.2. Automated
  • 8.4. Market Analysis, Insights and Forecast - By Test Type
    • 8.4.1. Laboratory Tests
    • 8.4.2. Point-of-Care Tests
  • 8.5. Market Analysis, Insights and Forecast - By Pathogen
    • 8.5.1. Bacterial
    • 8.5.2. Fungal
    • 8.5.3. Other Pathogens
  • 8.6. Market Analysis, Insights and Forecast - By End User
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostic Centres
    • 8.6.3. Others
  • 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.7.1. China
      • 8.7.1.1. By Product Type
    • 8.7.2. India
      • 8.7.2.1. By Product Type
    • 8.7.3. Japan
      • 8.7.3.1. By Product Type
    • 8.7.4. Australia
      • 8.7.4.1. By Product Type
    • 8.7.5. Rest of Asia Pacific
      • 8.7.5.1. By Product Type

9. Rest of the World Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Consumables
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Microbiology
    • 9.2.2. Molecular Diagnostics
    • 9.2.3. Immunoassays
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Method
    • 9.3.1. Conventional
    • 9.3.2. Automated
  • 9.4. Market Analysis, Insights and Forecast - By Test Type
    • 9.4.1. Laboratory Tests
    • 9.4.2. Point-of-Care Tests
  • 9.5. Market Analysis, Insights and Forecast - By Pathogen
    • 9.5.1. Bacterial
    • 9.5.2. Fungal
    • 9.5.3. Other Pathogens
  • 9.6. Market Analysis, Insights and Forecast - By End User
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostic Centres
    • 9.6.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. T2 Biosystems, Inc.
      • 10.2.1.1. Overview
      • 10.2.1.2. Product
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. financials (Based on Availability)
    • 10.2.2. Danaher
      • 10.2.2.1. Overview
      • 10.2.2.2. Product
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. financials (Based on Availability)
    • 10.2.3. Abbott
      • 10.2.3.1. Overview
      • 10.2.3.2. Product
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. financials (Based on Availability)
    • 10.2.4. bioMerieux SA
      • 10.2.4.1. Overview
      • 10.2.4.2. Product
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. financials (Based on Availability)
    • 10.2.5. Thermo Fisher Scientific Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Product
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. financials (Based on Availability)
    • 10.2.6. Luminex Corporation (DiaSorin S.p.A.)
      • 10.2.6.1. Overview
      • 10.2.6.2. Product
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. financials (Based on Availability)
    • 10.2.7. BD (Becton, Dickinson, and Company)
      • 10.2.7.1. Overview
      • 10.2.7.2. Product
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. financials (Based on Availability)
    • 10.2.8. Bruker
      • 10.2.8.1. Overview
      • 10.2.8.2. Product
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. financials (Based on Availability)
    • 10.2.9. Siemens Healthcare GmbH
      • 10.2.9.1. Overview
      • 10.2.9.2. Product
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. financials (Based on Availability)

List of Tables

  • Table 01: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 02: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 03: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 04: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 05: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 06: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 07: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Region, 2021-2034
  • Table 08: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 09: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 10: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 11: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 12: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 13: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 14: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 15: U.S. Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 16: Canada Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 17: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 18: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 19: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 20: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 21: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 22: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 23: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 24: Germany Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 25: U.K. Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 26: France Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 27: Italy Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 28: Spain Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 29: Rest of Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 30: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 31: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 32: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 33: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 34: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 35: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 36: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 37: China Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 38: India Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 39: Japan Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 40: Australia Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 41: Rest of Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 42: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 43: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 44: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 45: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 46: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 47: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034

List of Figures

  • Figure 01: Global Sepsis Diagnostics Market Revenue Breakdown (USD Billion, %), By Region, 2025 & 2034
  • Figure 02: Global Sepsis Diagnostics Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 03: Global Sepsis Diagnostics Market Value Share (%), By Technology, 2025 & 2034
  • Figure 04: Global Sepsis Diagnostics Market Value Share (%), By Method, 2025 & 2034
  • Figure 05: Global Sepsis Diagnostics Market Value Share (%), By Test Type, 2025 & 2034
  • Figure 06: Global Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025 & 2034
  • Figure 07: Global Sepsis Diagnostics Market Value Share (%), By End User, 2025 & 2034
  • Figure 08: Global Sepsis Diagnostics Market Value Share (%), By Region, 2025 & 2034
  • Figure 09: North America Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 10: North America Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 11: North America Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 12: North America Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 13: North America Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 14: North America Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 15: North America Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 16: North America Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 17: North America Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 18: North America Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 19: North America Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 20: North America Sepsis Diagnostics Market Value Share (%), By End User, 2025
  • Figure 21: North America Sepsis Diagnostics Market Value (USD million), By Country, 2025 & 2034
  • Figure 22: North America Sepsis Diagnostics Market Value Share (%), By Country, 2025
  • Figure 23: Europe Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 24: Europe Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 25: Europe Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 26: Europe Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 27: Europe Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 28: Europe Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 29: Europe Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 30: Europe Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 31: Europe Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 32: Europe Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 33: Europe Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 34: Europe Sepsis Diagnostics Market Value Share (%), By End User, 2025
  • Figure 35: Europe Sepsis Diagnostics Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 36: Europe Sepsis Diagnostics Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 37: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 38: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 39: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 40: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 41: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 42: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 43: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 44: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 45: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 46: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 47: Asia Pacific Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 48: Asia Pacific Sepsis Diagnostics Market Value Share (%), By End User, 2025
  • Figure 49: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 50: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 51: Rest of the World Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 52: Rest of the World Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 53: Rest of the World Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 54: Rest of the World Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 55: Rest of the World Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 56: Rest of the World Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 57: Rest of the World Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 58: Rest of the World Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 59: Rest of the World Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 60: Rest of the World Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 61: Rest of the World Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 62: Rest of the World Sepsis Diagnostics Market Value Share (%), By End User, 2025